Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00974142 · ClinicalTrials.gov registry record · Phase 1
Oral Cyclosporine in Chronic Obstructive Pulmonary Disease
A Phase 1 study, sponsored by Michael Donahoe.
- Completed
- Registry status
- Phase 1
- Development phase
- 43
- Enrollment target
NCT00974142 is a Phase 1 study that has completed, run by Michael Donahoe. The registered enrollment target is 43 participants.
The verdict
NCT00974142, a Phase 1 study, has completed, sponsored by Michael Donahoe.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 43 participants
- Enrollment target
Study Summary
This is a randomized, double-blinded, placebo-controlled trial of oral Cyclosporine A (CsA) in patients with advanced stage chronic obstructive pulmonary disease. The purpose of the study is to evaluate the safety and effectiveness of CsA as a therapy for the adaptive immune response in advanced stage Chronic Obstructive Pulmonary Disease (COPD). Subjects between 45 and 80 years of age with a confirmed diagnosis of advanced stage COPD, not responsive to conventional inhaler therapy, who meet all the study requirements, will be enrolled in this study. A total of 30 subjects of either sex will be enrolled in this study.
Interventions
- DRUG Placebo
- DRUG Cyclosporine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2009-09 |
| Est. Completion | 2016-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00974142
The ClinicalTrials.gov registry entry for NCT00974142 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michael Donahoe, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00974142 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00974142 about?
NCT00974142 is a clinical study titled "Oral Cyclosporine in Chronic Obstructive Pulmonary Disease". This is a randomized, double-blinded, placebo-controlled trial of oral Cyclosporine A (CsA) in patients with advanced stage chronic obstructive pulmonary disease. The purpose of the study is to evaluate the safety and effectiveness of CsA as a therapy for the adaptive immune response in advanced sta...
What is the current status of trial NCT00974142?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 43 participants. The study started on 2009-09. Estimated completion is 2016-12.
What interventions are being tested in trial NCT00974142?
The interventions under investigation include: Placebo (DRUG), Cyclosporine (DRUG).
Who is sponsoring clinical trial NCT00974142?
This trial is sponsored by Michael Donahoe, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.